Business

Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future

Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.

Previous post GM and Hyundai agree to explore collaboration on vehicles and manufacturing to reduce capital spending
Next post Moderna slashes research spending, trims pipeline as it looks to regain footing 

More Stories